GlassScriptPhysician profile
Elizabeth E Shieh
NPI 1558775692
$3,672.13
in general payments reported to CMS, 2019-2025
21 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $433 · 2022: $370 · 2023: $957 · 2024: $887 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,666 · Education: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,666.41 |
| Education | $202.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $881.31 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Glaxosmithkline, LLC. | $537.32 | 2021-2025 | Jemperli, Zejula |
| Astrazeneca Pharmaceuticals LP | $390.34 | 2021-2025 | Lynparza |
| Eisai INC. | $379.57 | 2021-2025 | |
| Abbvie INC. | $341.03 | 2024-2025 | |
| Astellas Pharma US INC | $226.84 | 2023-2024 | Veozah |
| Tempus Ai, INC | $140.99 | 2024-2025 | Xt Cdx |
| Immunogen, INC. | $112.55 | 2023 | Elahere |
| Clovis Oncology, INC. | $106.62 | 2021-2022 | |
| Daiichi Sankyo INC. | $102.30 | 2025 | Enhertu |
| Seagen INC. | $93.46 | 2021-2023 | Tivdak |
| Myriad Genetic Laboratories, INC. | $91.27 | 2021-2025 | Myrisk, Mychoice Cdx |
| Caris Mpi, INC. | $43.57 | 2025 | Mi Cancer Seek |
| Davol INC. | $39.13 | 2025 | |
| Genentech USA, INC. | $34.49 | 2025 | Tecentriq, Lunsumio, Columvi |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verastem, INC. | $30.38 | 2025 | Avmapki Fakzynja Co-Pack |
| Incyte Corporation | $28.63 | 2025 | Zynyz, Monjuvi |
| Regeneron Healthcare Solutions, INC. | $26.53 | 2023 | Libtayo |
| Baxter Healthcare | $25.48 | 2024 | Perclot |
| Tactile Systems Technology INC | $21.72 | 2023 | Entre Plus, Flexitouch Plus |
| Spectrum Pharmaceuticals INC. | $18.60 | 2024 | Rolvedon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Shieh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.